✦ LIBER ✦

Fidaxomicin for treatment of CDI: fewer recurrences at a cost

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fidaxomicin for CDI not cost effective a

✍ Laschober, Tanja C.; Tormes Eby, Lillian Turner 📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 128 KB

PIN35 Decision Analysis Model Evaluating

✍ Alowayesh, M.S.; Holdford, D.; Harpe, S.E. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Economic Evaluation of Fidaxomicin for t

✍ Van Engen, A.; Casamayor, M.; Loftus, F.; Crimin, E.; Lacey, L. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PIN29 Length of Stay and Cost Due to Rec

✍ N. Agthe; E. Mattila; T. Purmonen; M. Kanerva 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Impact of a chemoresponse assay on treat

✍ Laura J. Havrilesky; Thomas C. Krivak; John W. Mucenski; Evan R. Myers 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 237 KB

Exhaust gas treatment unit is made for A

📂 Article 📅 2013 🏛 Elsevier Science ⚖ 49 KB